Results 241 to 250 of about 3,908,770 (297)

The effect of asparagine-13 in porcine epidemic diarrhea virus envelope protein on pathogenicity. [PDF]

open access: yesVet Res
Li Z   +10 more
europepmc   +1 more source

Cell and Gene Therapies Manufacturing Challenges and Integrated Good Manufacturing Practices Solutions: A Lifecycle Perspective

open access: yesBiotechnology and Bioengineering, EarlyView.
Lifecycle perspective on cell and gene therapy manufacturing challenges and enabling GMP solutions. ABSTRACT Cell and gene therapies (CGTs) are revolutionizing modern medicine; however, making these advanced medicines scalable and readily available to commercial manufacturers worldwide is a major challenge. The number of approved CGT products continues
Rajath Samaga   +2 more
wiley   +1 more source

Enhanced strategies for cuproptosis‐like death in bacterial infection treatment

open access: yesBMEMat, EarlyView.
This review summarizes and examines the molecular mechanisms underlying cuproptosis‐like death. Furthermore, multi‐strategy efficacy enhancement and potential enhancement approaches are analyzed. Abstract Copper, a classical antibacterial metal, has long been of interest and widely used in medical and public health applications.
Wenqi Wang   +7 more
wiley   +1 more source

Generation of RNA aptamers against chikungunya virus E2 envelope protein. [PDF]

open access: yesJ Virol
Goto K   +6 more
europepmc   +1 more source

Inhibition of sulfated glycans on the binding of dengue virus envelope protein to heparin. [PDF]

open access: yesGlycoconj J
Yang J   +8 more
europepmc   +1 more source

Identification of Rhododendron mariae extraction as a new attachment inhibitor against dengue virus by targeting the envelope protein domain III. [PDF]

open access: yesFront Immunol
Tian C   +12 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy